Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study
Utilizing PROSE as a drug delivery system for non-preserved cyclosporine 0.05% was well tolerated in regard to both ocular symptoms and ocular surface signs. Results from this pilot study are suggestive of efficacy. The results of this study support progressing this protocol to a larger scale randomized controlled double blinded prospective clinical trial.
Authors
- Thelge Buddika Peiris (ORCID: https://orcid.org/0000-0001-9049-3248)
- M. Nakhla (ORCID: https://orcid.org/0009-0000-1883-7341)
- Daniel Brocks (ORCID: https://orcid.org/0000-0002-4163-0020)
- Estelle Crowley
- Ria Patel
- Yichen Li
Institutions
- Worcester Polytechnic Institute (US)
- Tufts University (US)
- Boston Foundation (US)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/opth.s487369
- Citations
- 3
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 1.63